No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial

Daniëlle de Jong, René Jansen, Willibrord Hoefnagels et al. · 2008

Read No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial by Daniëlle de Jong, René Jansen, Willibrord Hoefnagels et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001475.txt.

Description

Daniëlle de Jong and co-authors wrote a 2008 PLOS ONE trial report on a pain drug tested in Alzheimer's disease. Some had hoped that curbing brain swelling could slow memory loss. The drug tested is a broad anti swelling drug. The trial was blinded, with patients split at random to drug or dummy pills for one year.

The team report that one year of the drug did not slow the decline of the disease. That clear null result matters as much as a win would. It steers funds away from a weak lead. It also sharpens the case that swelling alone is not the driver of this disease.

Catalog record

CREATORDaniëlle de Jong, René Jansen, Willibrord Hoefnagels et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001475

Browse the full library · About the Tower of Babel